Which scoring system is effective in predicting mortality in patients with Crimean Congo hemorrhagic fever? A validation study

ArticleAçık Erişim

Özet

We aimed to decide which scoring system is the best for the evaluation of the course of Crimean-Congo Hemorrhagic Fever (CCHF) by comparing scoring systems such as qSOFA (quick Sequential Organ Failure Assessment), SOFA (Sequential Organ Failure Assessment), APACHE II (Acute Physiology and Chronic Health Evaluation II) and SGS (Severity Grading System) in centers where patients with CCHF were monitored. The study was conducted with patients diagnosed with CCHF in five different centers where the disease was encountered most commonly. Patients having proven PCR and/or IgM positivity for CCHF were included in the study. The scores of the scoring systems on admission, at the 72nd hour and at the 120th hour were calculated and evaluated. The data of 388 patients were obtained from five centers and evaluated. SGS, SOFA and APACHE II were the best scoring systems in predicting mortality on admission. All scoring systems were significant in predicting mortality at the 72nd and 120th hours. On admission, there was a correlation between the qSOFA, SOFA and APACHE II scores and the SGS scores in the group of survivors. All scoring systems had a positive correlation in the same direction. The correlation coefficients were strong for qSOFA and SOFA, but poor for APACHE II. A one-unit rise in SGS increased the probability of death by 12.818 times. qSOFA did not provide significant results in predicting mortality on admission. SGS, SOFA and APACHE II performed best at admission and at the 72nd and 120th hours. © 2021 Informa UK Limited, trading as Taylor & Francis Group.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12516Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBakir, Mehmet
dc.contributor.authorÖksüz, Caner
dc.contributor.authorKarakeçili, Faruk
dc.contributor.authorBaykam, Nurcan
dc.contributor.authorBarut, Şener
dc.contributor.authorBüyüktuna, Seyit Ali
dc.contributor.authorÖzkurt, Zülal
dc.contributor.authorÖz, Murteza
dc.contributor.authorBarkay, Orçun
dc.contributor.authorAkdoğan, Özlem
dc.contributor.authorElaldi, Nazif
dc.contributor.authorHasbek, Murşit
dc.contributor.authorEngin, Aynur
dc.date.accessioned2026-10-18T20:27:24.773714764Z
dc.date.available2026-10-18T20:27:24.773714764Z
dc.date.issued2022
dc.description.abstractWe aimed to decide which scoring system is the best for the evaluation of the course of Crimean-Congo Hemorrhagic Fever (CCHF) by comparing scoring systems such as qSOFA (quick Sequential Organ Failure Assessment), SOFA (Sequential Organ Failure Assessment), APACHE II (Acute Physiology and Chronic Health Evaluation II) and SGS (Severity Grading System) in centers where patients with CCHF were monitored. The study was conducted with patients diagnosed with CCHF in five different centers where the disease was encountered most commonly. Patients having proven PCR and/or IgM positivity for CCHF were included in the study. The scores of the scoring systems on admission, at the 72nd hour and at the 120th hour were calculated and evaluated. The data of 388 patients were obtained from five centers and evaluated. SGS, SOFA and APACHE II were the best scoring systems in predicting mortality on admission. All scoring systems were significant in predicting mortality at the 72nd and 120th hours. On admission, there was a correlation between the qSOFA, SOFA and APACHE II scores and the SGS scores in the group of survivors. All scoring systems had a positive correlation in the same direction. The correlation coefficients were strong for qSOFA and SOFA, but poor for APACHE II. A one-unit rise in SGS increased the probability of death by 12.818 times. qSOFA did not provide significant results in predicting mortality on admission. SGS, SOFA and APACHE II performed best at admission and at the 72nd and 120th hours. © 2021 Informa UK Limited, trading as Taylor & Francis Group.
dc.description.sponsorshipThe author(s) reported there is no funding associated with the work featured in this article. We thank the Refik Saydam Hygiene Center of Ankara, Turkey for testing the serum samples.
dc.identifier.doi10.1080/20477724.2021.2012921
dc.identifier.eissn2047-7732
dc.identifier.endpage200
dc.identifier.issn2047-7724
dc.identifier.issue3
dc.identifier.pmcidPMC9090416
dc.identifier.pmid34866547
dc.identifier.scopus2-s2.0-85121287529
dc.identifier.startpage193
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12516
dc.identifier.volume116
dc.identifier.wosWOS:000727170100001
dc.language.isoen
dc.publisherTaylor and Francis Ltd.
dc.relation.ispartofPathogens and Global Health
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAPACHE II
dc.subjectCrimean-Congo hemorrhagic fever
dc.subjectqSOFA
dc.subjectSGS
dc.subjectSOFA
dc.subjectHemorrhagic Fever Virus, Crimean-Congo
dc.subjectHemorrhagic Fever, Crimean
dc.subjectHumans
dc.subjectIntensive Care Units
dc.subjectOrgan Dysfunction Scores
dc.subjectPrognosis
dc.subjectRetrospective Studies
dc.subjectROC Curve
dc.subjectSeverity of Illness Index
dc.subjectcreatinine
dc.subjectimmunoglobulin G
dc.subjectimmunoglobulin M
dc.subjectpotassium
dc.subjectsodium
dc.subjectabdominal pain
dc.subjectadult
dc.subjectAPACHE
dc.subjectArticle
dc.subjectbleeding
dc.subjectbreathing rate
dc.subjectcontrolled study
dc.subjectcorrelation coefficient
dc.subjectcoughing
dc.subjectCrimean Congo hemorrhagic fever
dc.subjectdiagnostic test accuracy study
dc.titleWhich scoring system is effective in predicting mortality in patients with Crimean Congo hemorrhagic fever? A validation study
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus13
rdl.citation.wos13
rdl.departmentDepartment of Infectious Diseases and Clinical Microbiology, Erzincan Binali Yıldırım University, Mengücek Gazi Training and Research Hospital, Erzincan, Turkey.
rdl.oa.statusgreen
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)